MLL2 Antikörper (AA 1487-1587)
Kurzübersicht für MLL2 Antikörper (AA 1487-1587) (ABIN2611795)
Target
Alle MLL2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1487-1587
-
Marke
- IHC-plus™
-
Spezifität
- Human MLL2
-
Aufreinigung
- Purified from ascites by Protein A
-
Immunogen
-
MLL2 (NP_003473, 1487 a.a. ~ 1587 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG2a kappa
-
-
-
-
Applikationshinweise
-
Approved: ELISA, IHC, IHC-P (10 μg/mL), WB
Usage: Western Blot: Recombinant protein. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.4.
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid freeze-thaw cycles.
-
-
- MLL2 (Myeloid/lymphoid Or Mixed-Lineage Leukemia 2 (MLL2))
-
Andere Bezeichnung
- KMT2D / MLL2
-
Hintergrund
-
Name/Gene ID: KMT2D
Synonyms: KMT2D, AAD10, ALL1-related protein, KABUK1, KMS, Lysine N-methyltransferase 2D, MLL2, Kabuki make-up syndrome, ALR, CAGL114, KMT2B, Lysine N-methyltransferase 2B, TNRC21 -
Gen-ID
- 8085
-
NCBI Accession
- NP_003473
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Intracellular Steroid Hormone Receptor Signaling, Warburg Effekt
Target
-